Stocklytics Platform
Asset logo for symbol CDIO
Cardio Diagnostics Holdings
CDIO46
$0.46arrow_drop_up0.42%$0.00
Penny Stock
Asset logo for symbol CDIO
CDIO46

$0.46

arrow_drop_up0.42%

Performance History

Chart placeholder
Key Stats
Open$0.47
Prev. Close$0.46
EPS-0.75
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$10.57M
PE Ratio-
LOWHIGH
Day Range0.44
0.47
52 Week Range0.17
3.56
Ratios
Revenue-
EBITDA Margin %-
EPS-0.75

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$805.15
Perf. (24h)
arrow_drop_down1.95%-$16.03
Market Cap$738.87B
Price$570.00
Perf. (24h)
arrow_drop_up1.84%$10.32
Market Cap$527.83B
Price$160.66
Perf. (24h)
arrow_drop_up0.63%$1.02
Market Cap$382.01B
Price$185.19
Perf. (24h)
arrow_drop_up1.65%$3.02
Market Cap$326.96B

About Cardio Diagnostics Holdings (CDIO)

Cardio Diagnostics Holdings Inc. (CDIO) is a leading company in the field of cardiovascular diagnostics. The company specializes in developing and manufacturing innovative diagnostic tools and technologies for the early detection and monitoring of heart diseases. With a strong focus on research and development, CDIO has consistently been at the forefront of advancements in this field. The company's products are used by healthcare professionals worldwide to improve patient outcomes and reduce healthcare costs.
CDIO has a strong stock price history, with steady growth over the years. The company's stock has consistently outperformed the market and has provided significant returns to its shareholders. Investors have recognized the value of CDIO's innovative products and technologies, leading to an increase in the company's market cap. The stock has also gained attention from analysts, who have conducted detailed analysis on CDIO's financial performance and growth potential.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Meeshanthini V. Dogan Ph.D.
Headquarters
Chicago
Employees
7
Exchange
NASDAQ
add Cardio Diagnostics Holdings to watchlist

Keep an eye on Cardio Diagnostics Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the 52-week high and low for Cardio Diagnostics Holdings (CDIO)?
For Cardio Diagnostics Holdings (CDIO), the 52-week high is $3.56, which is 660.36% from the current price. The 52-week low is $0.17, the current price is 173.8% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
What is Cardio Diagnostics Holdings's (CDIO) price per share?
The current price per share for Cardio Diagnostics Holdings (CDIO) is $0.47. The stock has seen a price change of $0 recently, indicating a 0.47% change. This reflects the stock's recent market performance and investor sentiment.
help
Is Cardio Diagnostics Holdings (CDIO) a growth stock?
Cardio Diagnostics Holdings (CDIO) has shown an average price growth of 0.41% over the past three years. It has received a score of -2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cardio Diagnostics Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Cardio Diagnostics Holdings (CDIO) stock price performance year to date (YTD)?
As of the latest data, Cardio Diagnostics Holdings (CDIO) has a year-to-date price change of -84.7%. Over the past month, the stock has experienced a price change of -15.03%. Over the last three months, the change has been -35.19%. Over the past six months, the figure is -77.05%.
help
Is Cardio Diagnostics Holdings (CDIO) a profitable company?
Cardio Diagnostics Holdings (CDIO) has a net income of -$8.38M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -26.11K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$7.24M. Furthermore, the EBITDA is -$9.56M.
help
What is the market capitalization of Cardio Diagnostics Holdings (CDIO)?
Cardio Diagnostics Holdings (CDIO) has a market capitalization of $10.57M. The average daily trading volume is 181.11K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level